ICON plc logo

ICON plc (ICLR)

Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
161. 40
-3.59
-2.1759%
$
12.93B Market Cap
39.68 P/E Ratio
- Div Yield
604,609 Volume
14.93 Eps
$ 164.99
Previous Close
Add Transaction
Day Range
160.01 164.74
Year Range
66.57 203.91
Want to track ICLR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Icon PLC (ICLR) Q2 Earnings Surpass Estimates

Icon PLC (ICLR) Q2 Earnings Surpass Estimates

Icon PLC (ICLR) came out with quarterly earnings of $3.75 per share, beating the Zacks Consensus Estimate of $3.69 per share. This compares to earnings of $3.11 per share a year ago.

Zacks | 2 years ago
Why Icon PLC (ICLR) is a Top Growth Stock for the Long-Term

Why Icon PLC (ICLR) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 years ago
3 Reasons Why Growth Investors Shouldn't Overlook Icon PLC (ICLR)

3 Reasons Why Growth Investors Shouldn't Overlook Icon PLC (ICLR)

Icon PLC (ICLR) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 2 years ago
Why Icon PLC (ICLR) is a Top Momentum Stock for the Long-Term

Why Icon PLC (ICLR) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 years ago
ICLR vs. GDRX: Which Stock Is the Better Value Option?

ICLR vs. GDRX: Which Stock Is the Better Value Option?

Investors with an interest in Medical Services stocks have likely encountered both Icon PLC (ICLR) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks is more attractive to value investors?

Zacks | 2 years ago
ICON: Deleveraging Complete, Now See 18% CAGR In Valuation To FY'26E (Rating Upgrade)

ICON: Deleveraging Complete, Now See 18% CAGR In Valuation To FY'26E (Rating Upgrade)

ICON acquired PRA Health Sciences in a $12B deal in 2020, creating a new company. The stock has doubled since the acquisition, and could be worth $370-$400/share based on earnings estimates and excess earnings above assets of similar price and risk. Its strong order book, earnings leverage, and attractive valuations support a buy recommendation.

Seekingalpha | 2 years ago
Here's Why Icon PLC (ICLR) is a Strong Value Stock

Here's Why Icon PLC (ICLR) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 2 years ago
Icon PLC (ICLR) is on the Move, Here's Why the Trend Could be Sustainable

Icon PLC (ICLR) is on the Move, Here's Why the Trend Could be Sustainable

Icon PLC (ICLR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Zacks | 2 years ago
Is Icon PLC (ICLR) a Solid Growth Stock? 3 Reasons to Think "Yes"

Is Icon PLC (ICLR) a Solid Growth Stock? 3 Reasons to Think "Yes"

Icon PLC (ICLR) possesses solid growth attributes, which could help it handily outperform the market.

Zacks | 2 years ago
Why Icon PLC (ICLR) is a Top Value Stock for the Long-Term

Why Icon PLC (ICLR) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 years ago
Here's Why Icon PLC (ICLR) is a Strong Momentum Stock

Here's Why Icon PLC (ICLR) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 years ago
Why Icon PLC (ICLR) is a Top Growth Stock for the Long-Term

Why Icon PLC (ICLR) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 2 years ago
Loading...
Load More